Hostname: page-component-745bb68f8f-grxwn Total loading time: 0 Render date: 2025-01-09T06:37:42.772Z Has data issue: false hasContentIssue false
  • English
  • Français

Safety and tolerability meta-analysis of aripiprazole in schizophrenia

Published online by Cambridge University Press:  16 April 2020

W.H. Carson ,
E. Stock ,
A.R. Saha ,
M.W. Ali ,
R.D. McQuade ,
M.J. Kujawa  and
G. Ingenito
W.H. Carson
Affiliation:
Bristol-Myers Squibb, Wallingford, CT
E. Stock
Affiliation:
Bristol-Myers Squibb, Wallingford, CT
A.R. Saha
Affiliation:
Otsuka Maryland Research Institute, USA
M.W. Ali
Affiliation:
Otsuka Maryland Research Institute, USA
R.D. McQuade
Affiliation:
Bristol-Myers Squibb, Wallingford, CT
M.J. Kujawa
Affiliation:
Bristol-Myers Squibb, Wallingford, CT
G. Ingenito
Affiliation:
Otsuka Maryland Research Institute, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Sunday, 5 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 106s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.